Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw strong trading volume on Tuesday . 20,000 shares traded hands during mid-day trading, an increase of 176% from the previous session’s volume of 7,258 shares.The stock last traded at $7.93 and had previously closed at $7.99.
Oxford BioMedica Stock Performance
The company’s 50 day moving average is $8.08 and its 200-day moving average is $8.94.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Further Reading
- Five stocks we like better than Oxford BioMedica
- Thematic Memory ETFs Give Investors a New Way to Play AI’s Hidden Bottleneck
- Rocket Lab Has Corrected Nearly 50%. Is It Still Too Expensive?
- Cybersecurity ETFs Are Rallying While AI Stocks Cool Off
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
